Association Between Travel Length and Drug Use Among Brazilian Truck Drivers
Carregando...
Citações na Scopus
25
Tipo de produção
article
Data de publicação
2015
Título da Revista
ISSN da Revista
Título do Volume
Editora
TAYLOR & FRANCIS INC
Autores
PRADO, Natanael Vitoriano Do
OLIVEIRA, Keziah Cristina Barbosa Gruber De
YONAMINE, Mauricio
GJERDE, Hallvard
Citação
TRAFFIC INJURY PREVENTION, v.16, n.1, p.5-9, 2015
Resumo
Objective: To investigate whether the use of the stimulants amphetamines and cocaine by truck drivers in Brazil was related to travel length. Methods: Truck drivers were randomly stopped by the Federal Highway Police on interstate roads in Sao Paulo State during morning hours from 2008 to 2011 and invited to participate in the project ""Comandos de Saude nas Rodovias"" (Health Commands on the Roads). Participants were asked about the use of drugs, travel distance, and age, and gender was recorded. Samples of urine were collected and analyzed for amphetamine, benzoylecgonine (a metabolite of cocaine), and carboxytetrahydrocannabinol (THC-COOH; a metabolite of cannabis) by immunological screening and quantification by gas chromatography-mass spectroscopy. Results: Current use of amphetamine, cocaine, and cannabis was reported by 5.7%, 0.7%, and 0.3% of the truck drivers, respectively. Amphetamine, benzoylecgonine, and THC-COOH were found in urine samples from 5.4%, 2.6,% and in 1.0% of the drivers, respectively. There was a significant association between the positive cases for amphetamine and reported travel length; 9.9% of urine samples from drivers who reported travel length of more than 270km were positive for amphetamine, and 10.9% of those drivers reported current use of amphetamines. In most cases, appetite suppressants containing amphetamines had been used, but the purpose was most often to stay awake and alert while driving. Truck drivers with travel length of more than 270km had significantly higher odds ratio (OR) for having a urine sample that was positive for amphetamine when adjusted for age as confounding factor (OR = 9.41, 95% confidence interval [CI], 3.97-22.26). No significant association was found between the use of cocaine or cannabis and travel length. Conclusion: Truck drivers who reported driving more than 270km had significantly higher frequencies of urine samples positive for amphetamine and reported significantly more frequent current use of amphetamines than those who reported shorter driving distances.
Palavras-chave
drugs, toxicology, trucks, driver behavior
Referências
- Bernhoft IM, 2012, PROCD SOC BEHV, V48, P2907, DOI 10.1016/j.sbspro.2012.06.1259
- Caldwell JA, 2003, AVIAT SPACE ENVIR MD, V74, P1125
- CATANIA JA, 1990, HEALTH EDUC QUART, V17, P53, DOI 10.1177/109019819001700107
- Cody JT, 2002, J OCCUP ENVIRON MED, V44, P435, DOI 10.1097/00043764-200205000-00012
- Comiran E, 2012, THER DRUG MONIT, V34, P545, DOI 10.1097/FTD.0b013e318263c6c5
- Departamento Nacional de Transito (National Traffic Department) (DENATRAN), 2006, IMP SOC EC AC TRANS
- European Union, 2006, OFF J EUR UN, V49, P1
- Federal Motor Carrier Safety Administration, 2011, FED REG, V76, P81134
- Federal Motor Carrier Safety Administration, DOT FMCSA DRUG ALC T
- Friswell R, 2008, ACCIDENT ANAL PREV, V40, P410, DOI 10.1016/j.aap.2007.07.009
- Gates J, 2013, FORENSIC SCI INT, V228, P15, DOI 10.1016/j.forsciint.2013.02.001
- Gjerde H, 2013, TRANSPORT RES F-TRAF, V17, P134, DOI 10.1016/j.trf.2012.11.004
- Gustafson RA, 2003, J CHROMATOGR B, V798, P145, DOI 10.1016/j.jchromb.2003.09.022
- Hjalmdahl M, 2012, PSYCHOPHARMACOLOGY, V222, P401, DOI 10.1007/s00213-012-2744-7
- Hosmer D. W., 2000, APPL LOGISTIC REGRES
- KELLY TH, 1991, PHARMACOL BIOCHEM BE, V38, P417, DOI 10.1016/0091-3057(91)90301-H
- Knauth DR, 2012, REV SAUDE PUBL, V46, P886, DOI 10.1590/S0034-89102012000500016
- Leyton V, 2012, FORENSIC SCI INT, V215, P25, DOI 10.1016/j.forsciint.2011.03.032
- Mabbott NA, 1999, TRANSPORT RES F-TRAF, V2, P115, DOI 10.1016/S1369-8478(99)00012-1
- do Nascimento EC, 2007, REV SAUDE PUBL, V41, P290, DOI 10.1590/S0034-89102007000200017
- National Transport Commission, 2008, HEAV VEH DRIV FAT RE
- Newcombe RG, 1998, STAT MED, V17, P857, DOI 10.1002/(SICI)1097-0258(19980430)17:8<857::AID-SIM777>3.0.CO;2-E
- Noce F, 2008, SLEEP SCI, V1, P20
- Oliveira Lúcio Garcia de, 2013, Cad Saude Publica, V29, P1903
- Pinho RS, 2006, CHRONOBIOL INT, V23, P963, DOI 10.1080/07420520600920759
- Robb G, 2008, INJURY PREV, V14, P51, DOI 10.1136/ip.2007.016766
- Scheidweiler KB, 2006, J CHROMATOGR B, V835, P90, DOI 10.1016/j.jchromb.2006.03.020
- Silber BY, 2005, PSYCHOPHARMACOLOGY, V179, P536, DOI 10.1007/s00213-004-2061-x
- Silva OA, 2003, DRUG-EDUC PREV POLIC, V10, P135, DOI 10.1080/0968763021000057727
- Starmer GA, 1994, ANAL DRUGS SALIVA
- STILLMAN R, 1993, PSYCHOPHARMACOLOGY, V110, P415, DOI 10.1007/BF02244647
- Takitane J, 2013, CIENC SAUDE COLETIVA, V18, P1247
- Ulhoa MA, 2010, REV SAUDE PUBL, V44, P1130, DOI 10.1590/S0034-89102010000600019
- US Department of Transportation, 2012, PROC TRANSP WORKPL D
- Wendler EA, 2003, PUBL UEPG CI BIOL SA, V9, P7
- Wilson EB, 1927, J AM STAT ASSOC, V22, P209, DOI 10.2307/2276774
- Yonamine M, 2002, J CHROMATOGR B, V773, P83, DOI 10.1016/S0378-4347(01)00516-3
- Zancanaro I, 2012, FORENSIC SCI INT, V223, P208, DOI 10.1016/j.forsciint.2012.08.048